MA37751B1 - Procédé de préparation de composés d'acides aminés - Google Patents

Procédé de préparation de composés d'acides aminés

Info

Publication number
MA37751B1
MA37751B1 MA37751A MA37751A MA37751B1 MA 37751 B1 MA37751 B1 MA 37751B1 MA 37751 A MA37751 A MA 37751A MA 37751 A MA37751 A MA 37751A MA 37751 B1 MA37751 B1 MA 37751B1
Authority
MA
Morocco
Prior art keywords
preparation
amino acid
acid compounds
isopropylamino
cyclopenta
Prior art date
Application number
MA37751A
Other languages
English (en)
Other versions
MA37751A1 (fr
Inventor
Travis Remarchuk
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MA37751A1 publication Critical patent/MA37751A1/fr
Publication of MA37751B1 publication Critical patent/MA37751B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/313Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/32Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cette invention concerne de nouveaux procédés de préparation et de purification de composés d'acides aminés, qui sont utiles dans la préparation des inhibiteurs d'akt utilisés dans le traitement des maladies telles que le cancer, comprenant le composé de (s)-2-(4-chlorophényl)-1-(4-((5r,7r)- 7-hydroxy-5-méthyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl)pipérazin-1-yl)-3-(isopropylamino)propan-1-one.
MA37751A 2012-05-17 2013-05-17 Procédé de préparation de composés d'acides aminés MA37751B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261648534P 2012-05-17 2012-05-17
PCT/US2013/041687 WO2013173779A1 (fr) 2012-05-17 2013-05-17 Procédé de préparation de composés d'acides aminés

Publications (2)

Publication Number Publication Date
MA37751A1 MA37751A1 (fr) 2018-01-31
MA37751B1 true MA37751B1 (fr) 2018-08-31

Family

ID=48483247

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37751A MA37751B1 (fr) 2012-05-17 2013-05-17 Procédé de préparation de composés d'acides aminés

Country Status (21)

Country Link
US (1) US9278917B2 (fr)
EP (1) EP2850054B1 (fr)
JP (1) JP6196294B2 (fr)
KR (1) KR102074535B1 (fr)
CN (1) CN104520263B (fr)
AU (1) AU2013262516B2 (fr)
BR (1) BR112014028585B1 (fr)
CA (1) CA2873658C (fr)
ES (1) ES2668477T3 (fr)
HR (1) HRP20180948T1 (fr)
IL (1) IL235630A (fr)
MA (1) MA37751B1 (fr)
MX (1) MX350443B (fr)
MY (1) MY171538A (fr)
NZ (1) NZ702939A (fr)
PL (1) PL2850054T3 (fr)
RU (1) RU2643146C2 (fr)
SG (1) SG11201407625WA (fr)
SI (1) SI2850054T1 (fr)
TR (1) TR201807444T4 (fr)
WO (1) WO2013173779A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014013865A (es) 2012-05-17 2015-05-07 Genentech Inc Proceso para elaborar compuestos de ciclopentilpirimidina hidroxilada.
BR112014028589B1 (pt) 2012-05-17 2022-08-23 Genentech, Inc. Ciclopentilpirimidina hidroxilada, seu processo de fabricação e seus intermediários
KR102678074B1 (ko) 2012-05-17 2024-06-26 제넨테크, 인크. 무정형 형태의 akt 저해성 피리미디닐 - 사이클로펜탄 화합물, 조성물 및 이들의 방법
CN104471070B (zh) 2012-05-17 2018-09-25 基因泰克公司 制备羟基化环戊并嘧啶化合物和其盐的方法
EP3068770B1 (fr) * 2013-11-15 2019-10-23 F.Hoffmann-La Roche Ag Procédé de préparation de composés de pyrimidinylcyclopentane
MX368298B (es) * 2014-09-26 2019-09-27 Hoffmann La Roche Procesos para preparar compuestos de (ciclopentil [d]pirimidin-4-il)piperazina.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
CA2178829A1 (fr) 1993-12-12 1995-06-15 Yigal Cohen Nouveau procede servant a proteger des vegetaux des infections fongiques
CA2286239A1 (fr) 1997-04-07 1998-10-15 Merck & Co., Inc. Procede de traitement du cancer
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (fr) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines comme antagonistes du recepteur histamine H3 et leur application thérapeutique
EP1158982A4 (fr) 1999-03-03 2002-06-12 Merck & Co Inc Inhibiteurs de la prenyle-proteine transferase
AU7715300A (en) 1999-09-27 2001-04-30 Merck & Co., Inc. Method of preventing osteoporosis
CA2526506A1 (fr) 2003-06-09 2004-12-16 Boehringer Ingelheim International Gmbh Inhibiteurs du papillomavirus
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
UA95641C2 (xx) 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2209775A1 (fr) 2007-10-09 2010-07-28 UCB Pharma, S.A. Composés hétérobicycliques utiles comme antagonistes du récepteur h4 de l'histamine
CN102459165B (zh) 2009-04-15 2015-09-02 Abbvie公司 抗病毒化合物
WO2011050016A1 (fr) 2009-10-23 2011-04-28 Eli Lilly And Company Inhibiteurs d'akt
PT2592933T (pt) 2010-07-16 2017-05-23 Gaweco Anderson Inibidores de mif e suas utilizações
WO2012177925A1 (fr) 2011-06-21 2012-12-27 The Board Institute, Inc. Inhibiteurs akt pour le traitement d'un cancer exprimant un gène de fusion magi3 - akt3
CN104471070B (zh) 2012-05-17 2018-09-25 基因泰克公司 制备羟基化环戊并嘧啶化合物和其盐的方法
MX2014013865A (es) 2012-05-17 2015-05-07 Genentech Inc Proceso para elaborar compuestos de ciclopentilpirimidina hidroxilada.
US20140121193A1 (en) 2012-11-01 2014-05-01 Robert S. Katz Methods for treating fibromyalgia
US20150376198A1 (en) 2013-02-18 2015-12-31 The Scripps Research Institute Modulators of vasopressin receptors with therapeutic potential
EP2968318A4 (fr) 2013-03-15 2016-12-14 Shifa Biomedical Corp Composés anti-pcsk9 et méthodes de traitement et/ou de prévention de maladies cardio-vasculaires

Also Published As

Publication number Publication date
HRP20180948T1 (hr) 2018-08-10
JP2015520165A (ja) 2015-07-16
MA37751A1 (fr) 2018-01-31
SG11201407625WA (en) 2014-12-30
US20150148559A1 (en) 2015-05-28
RU2643146C2 (ru) 2018-01-31
BR112014028585B1 (pt) 2020-12-22
MX350443B (es) 2017-09-06
TR201807444T4 (tr) 2018-06-21
SI2850054T1 (en) 2018-06-29
AU2013262516B2 (en) 2017-10-19
MY171538A (en) 2019-10-17
PL2850054T3 (pl) 2018-08-31
NZ702939A (en) 2016-08-26
KR20150013808A (ko) 2015-02-05
CN104520263B (zh) 2016-11-09
EP2850054A1 (fr) 2015-03-25
EP2850054B1 (fr) 2018-03-21
JP6196294B2 (ja) 2017-09-13
IL235630A (en) 2017-03-30
CA2873658A1 (fr) 2013-11-21
CN104520263A (zh) 2015-04-15
AU2013262516A1 (en) 2015-01-22
WO2013173779A1 (fr) 2013-11-21
BR112014028585A8 (pt) 2020-09-24
HK1208857A1 (en) 2016-03-18
RU2014150991A (ru) 2016-07-10
IL235630A0 (en) 2015-02-01
US9278917B2 (en) 2016-03-08
CA2873658C (fr) 2021-01-26
BR112014028585A2 (pt) 2017-06-27
KR102074535B1 (ko) 2020-02-06
MX2014013863A (es) 2015-05-07
ES2668477T3 (es) 2018-05-18

Similar Documents

Publication Publication Date Title
MA37647A1 (fr) Procédé de fabrication de composés de cyclopentapyrimidine hydroxylée et sels de ceux-ci
MA37751A1 (fr) Procédé de préparation de composés d'acides aminés
EA202091709A1 (ru) Ингибиторы днк-пк
MA37649A1 (fr) Procédé de fabrication de composés cyclopentylpyrimidines hydroxylées
MA32889B1 (fr) Composes de pyrazine comme inhibiteurs de phosphodiesterase 10
MA41134B1 (fr) Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales
EA201101666A1 (ru) 3-[4-(7H-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1H-ПИРАЗОЛ-1-ИЛ]ОКТАН- ИЛИ ГЕПТАННИТРИЛ КАК JAK-ИНГИБИТОРЫ
MY196260A (en) Small Molecule Inhibitors of the Jak Family Of Kinases
CY1112253T1 (el) Ενωσεις διαμινοτριαζολιου χρησιμες ως αναστολεις κινασης πρωτεϊνης
EA200901138A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
MA31167B1 (fr) Inhibiteurs de l'activite de akt
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
MX2010005300A (es) 4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpir imidin-2-aminas como inhibidores de cinasas janus.
MX361992B (es) Compuestos de pirrolopirimidina novedosos como inhibidores de proteínas quinasas.
MX2009009591A (es) Aminopirimidinas utiles como inhibidores de proteinas cinasas.
EA201291143A1 (ru) Пиразолилхиназолиновые ингибиторы киназы
WO2010147898A3 (fr) Inhibiteurs à petite molécule de la tyrosine kinase de la rate (syk)
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
MX336051B (es) Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa.
EA201891067A1 (ru) [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИН-7-ИЛЬНОЕ СОЕДИНЕНИЕ
MA39170B1 (fr) Composes inhibiteurs de sérine/thréonine kinase pour leurs utilisations dans le traitement du cancer
NZ703343A (en) Phenyl amino pyrimidine bicyclic compounds and uses thereof
GB201302704D0 (en) Therapeutic compounds